(3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide

C73H105ClF3N13O12S — CID 171917150

IUPAC(3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)C[C@@H](C(=O)N(C)C)N(C)C(=O)[C@H]([C@@H](C)CC)N(C)C(=O)C2(CCCC2)NC(=O)[C@H](Cc2cscn2)N(C)C(=O)[C@H](CCc2ccc(C(F)(F)F)c(Cl)c2)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(C)cc2)N(C)C(=O)C2CCN2C(=O)[C@H](C)N(C)C1=O
InChIInChI=1S/C73H105ClF3N13O12S/c1-18-44(6)60-69(100)84(12)46(8)64(95)90-33-30-53(90)68(99)87(15)56(36-48-24-22-43(5)23-25-48)67(98)83(11)39-58(91)79-52(29-27-47-26-28-50(51(74)35-47)73(75,76)77)65(96)86(14)55(37-49-40-103-41-78-49)63(94)81-72(31-20-21-32-72)71(102)89(17)61(45(7)19-2)70(101)88(16)57(66(97)82(9)10)38-59(92)85(13)54(34-42(3)4)62(93)80-60/h22-26,28,35,40-42,44-46,52-57,60-61H,18-21,27,29-34,36-39H2,1-17H3,(H,79,91)(H,80,93)(H,81,94)/t44-,45-,46-,52-,53?,54-,55-,56-,57-,60-,61-/m0/s1
InChIKeyZYCWIDXXVANSOJ-YBRKRDJVSA-N
MW1481.24 g/mol
LogP5.61
Rot. Bonds14

About (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide

(3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide (PubChem CID 171917150) has the molecular formula C73H105ClF3N13O12S and a molecular weight of 1481.24 g/mol. Its IUPAC name is (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide.

Molecular Properties

Compound Name(3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide
PubChem CID171917150
Molecular FormulaC73H105ClF3N13O12S
Molecular Weight1481.24 g/mol
Exact Mass1479.74
IUPAC Name(3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)C[C@@H](C(=O)N(C)C)N(C)C(=O)[C@H]([C@@H](C)CC)N(C)C(=O)C2(CCCC2)NC(=O)[C@H](Cc2cscn2)N(C)C(=O)[C@H](CCc2ccc(C(F)(F)F)c(Cl)c2)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(C)cc2)N(C)C(=O)C2CCN2C(=O)[C@H](C)N(C)C1=O
InChIInChI=1S/C73H105ClF3N13O12S/c1-18-44(6)60-69(100)84(12)46(8)64(95)90-33-30-53(90)68(99)87(15)56(36-48-24-22-43(5)23-25-48)67(98)83(11)39-58(91)79-52(29-27-47-26-28-50(51(74)35-47)73(75,76)77)65(96)86(14)55(37-49-40-103-41-78-49)63(94)81-72(31-20-21-32-72)71(102)89(17)61(45(7)19-2)70(101)88(16)57(66(97)82(9)10)38-59(92)85(13)54(34-42(3)4)62(93)80-60/h22-26,28,35,40-42,44-46,52-57,60-61H,18-21,27,29-34,36-39H2,1-17H3,(H,79,91)(H,80,93)(H,81,94)/t44-,45-,46-,52-,53?,54-,55-,56-,57-,60-,61-/m0/s1
InChIKeyZYCWIDXXVANSOJ-YBRKRDJVSA-N
XLogP5.61
TPSA282.98 Ų
H-Bond Donors3
H-Bond Acceptors14
Rotatable Bonds14
Heavy Atoms103
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001481.24
LogP ≤ 55.61
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1014

Analyze (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide?
The IUPAC name of (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide (CID 171917150) is (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide.
What is the SMILES notation for (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide?
The canonical SMILES for (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide is CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)C[C@@H](C(=O)N(C)C)N(C)C(=O)[C@H]([C@@H](C)CC)N(C)C(=O)C2(CCCC2)NC(=O)[C@H](Cc2cscn2)N(C)C(=O)[C@H](CCc2ccc(C(F)(F)F)c(Cl)c2)NC(=O)CN(C)C(=O)[C@H](Cc2ccc(C)cc2)N(C)C(=O)C2CCN2C(=O)[C@H](C)N(C)C1=O.
What is the InChIKey of (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide?
The InChIKey is ZYCWIDXXVANSOJ-YBRKRDJVSA-N. The full InChI is InChI=1S/C73H105ClF3N13O12S/c1-18-44(6)60-69(100)84(12)46(8)64(95)90-33-30-53(90)68(99)87(15)56(36-48-24-22-43(5)23-25-48)67(98)83(11)39-58(91)79-52(29-27-47-26-28-50(51(74)35-47)73(75,76)77)65(96)86(14)55(37-49-40-103-41-78-49)63(94)81-72(31-20-21-32-72)71(102)89(17)61(45(7)19-2)70(101)88(16)57(66(97)82(9)10)38-59(92)85(13)54(34-42(3)4)62(93)80-60/h22-26,28,35,40-42,44-46,52-57,60-61H,18-21,27,29-34,36-39H2,1-17H3,(H,79,91)(H,80,93)(H,81,94)/t44-,45-,46-,52-,53?,54-,55-,56-,57-,60-,61-/m0/s1.
What are the key properties of (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide?
(3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide has a molecular weight of 1481.24 g/mol, XLogP of 5.61, 14 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,6S,9S,13S,16S,22S,25S,31S)-6,16-bis[(2S)-butan-2-yl]-25-[2-[3-chloro-4-(trifluoromethyl)phenyl]ethyl]-N,N,3,4,10,14,17,23,29,32-decamethyl-31-[(4-methylphenyl)methyl]-9-(2-methylpropyl)-2,5,8,11,15,18,21,24,27,30,33-undecaoxo-22-(1,3-thiazol-4-ylmethyl)spiro[1,4,7,10,14,17,20,23,26,29,32-undecazabicyclo[32.2.0]hexatriacontane-19,1'-cyclopentane]-13-carboxamide is sourced from PubChem (CID 171917150), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).